Search results
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 14 hours agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
Lone Star College invests $500K into Montgomery campus' biotechnology program
Community Impact· 17 hours agoThe Lone Star College-Montgomery Biotechnology Institute will be expanding its offerings and...
Traders Buy Large Volume of Put Options on iShares Biotechnology ETF (NASDAQ:IBB)
ETF DAILY NEWS· 1 day agoiShares Biotechnology ETF (NASDAQ:IBB – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors purchased 70,278 put options on ...
Asia Green Biotechnology Corp. Announces Filing of Financial Statements on SEDAR
Morningstar· 10 hours ago[NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES] CALGARY, AB / ACCESSWIRE / May 24, 2024 / Asia Green Biotechnology Corp. ("Asia Green" or ...
Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options
Zacks via Yahoo Finance· 5 days agoInvestors in Puma Biotechnology, Inc. PBYI need to pay close attention to the stock based on moves...
Adaptive Biotechnologies Corp (ADPT) Shares Down Despite Recent Market Volatility – News Heater
NewsHeater· 2 days agoAdaptive Biotechnologies Corp (NASDAQ: ADPT)’s stock price has decreased by -3.16 compared to its previous closing price of 3.46. Is It Worth Investing in Adaptive Biotechnologies Corp (NASDAQ ...
IMC Chicago LLC Purchases New Stake in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
ETF DAILY NEWS· 20 hours agoIMC Chicago LLC bought a new position in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Free Report) in the 4th quarter, according to the company in its ...
Renovaro teams up with Amsterdam UMC for cancer therapy By Investing.com
Investing.com· 13 hours agoRenovaro Inc. (NASDAQ: RENB), a biotechnology company, has announced a partnership with the...
Traders Buy Large Volume of Merus Put Options (NASDAQ:MRUS)
ETF DAILY NEWS· 4 hours agoMerus (NASDAQ:MRUS – Get Free Report) was the recipient of unusually large options trading on Friday. Merus has a fifty-two week low of $19.81 and a fifty-two week high of $61.61. Merus (NASDAQ ...
Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks
InvestorPlace· 19 hours agoInnovation has been a hallmark of biotechnology for decades and, despite some of the hardest...